Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.6%

45 terminated/withdrawn out of 806 trials

Success Rate

86.5%

+0.0% vs industry average

Late-Stage Pipeline

17%

139 trials in Phase 3/4

Results Transparency

6%

18 of 289 completed trials have results

Key Signals

186 recruiting18 with results37 terminated8 withdrawn

Enrollment Performance

Analytics

N/A
278(53.7%)
Phase 4
79(15.3%)
Phase 2
66(12.7%)
Phase 3
60(11.6%)
Phase 1
33(6.4%)
Early Phase 1
2(0.4%)
518Total
N/A(278)
Phase 4(79)
Phase 2(66)
Phase 3(60)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (806)

Showing 20 of 806 trials
NCT05263362Completed

An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)

Role: lead

NCT03540420Phase 2Active Not Recruiting

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Role: collaborator

NCT07402109Not ApplicableRecruiting

CBCT Guided Markerless SBRT for Renal Cell Cancer

Role: lead

NCT07497724Not Yet Recruiting

Retrospective Observational Study of Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)

Role: collaborator

NCT07491328Recruiting

Liquid Biopsy in Paraneoplastic Neurological Syndromes

Role: collaborator

NCT07485452Phase 2Not Yet Recruiting

Boosting Osimertinib Blood Brain Barrier Penetration

Role: collaborator

NCT07482124Recruiting

Multicenter Registry of Patients With Subarachnoid Hemorrhage

Role: collaborator

NCT05774548Not ApplicableRecruiting

LA PrEP Impact and Cost-effectiveness (TEAMS)

Role: collaborator

NCT06505109Not ApplicableRecruiting

OPTImizing CArdiac REhabilitation by REfining Sleep and STress

Role: lead

NCT05282082Completed

Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

Role: lead

NCT07455097Active Not Recruiting

COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

Role: collaborator

NCT07402343Phase 2Not Yet Recruiting

Tarlatamab for SCLC Brain Metastases

Role: collaborator

NCT07437482Not Yet Recruiting

Cancer Literacy Education and Awareness Resources for Prostate Care

Role: collaborator

NCT04243005Not ApplicableActive Not Recruiting

Supramarginal Resection in Glioblastoma

Role: collaborator

NCT05489380Not ApplicableCompleted

Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance

Role: collaborator

NCT07435987Not ApplicableNot Yet Recruiting

Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy

Role: lead

NCT06700018Recruiting

Flow Patterns and Stent Thrombosis

Role: collaborator

NCT07440147Not ApplicableRecruiting

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers

Role: collaborator

NCT07426575Not Yet Recruiting

Evaluating the Usability of New Dialysis Bags

Role: lead

NCT06101745Phase 2Recruiting

Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery

Role: collaborator